Trial Profile
A phase II study of antofloxacin, a novel fluoroquinolone, for the treatment of acute bacterial infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2011
Price :
$35
*
At a glance
- Drugs Antofloxacin (Primary) ; Levofloxacin
- Indications Bacterial infections; Bronchitis; Pyelonephritis
- Focus Therapeutic Use
- 07 Mar 2011 New trial record